Introduction


As we were working on a Treatment Plasmid that could induce apoptosis in endometrial-like cells and leave the healthy endometrium unaffected, we needed to find a way to test if the plasmid would be able to do that.

Our Treatment Plasmid contains two different composite parts BBa_K5253007 and BBa_K5253008:

  • BBa_K5253007 consist of promoter: CD47’s promoter, Gene: BAX, Terminator: SV40
  • BBa_K5253008 consist of promoter: BRCA1’s promoter, Gene: BCL2, Terminator: SV40

We also made a Control Plasmid to ensure that our promoters perform as expected.

Our Control Plasmid contains two different composite parts BBa_K5253009 and BBa_K5253010:

  • BBa_K5253009 consist of promoter: CD47’s promoter, Gene: DsRed1, Terminator: SV40
  • BBa_K5253010 consist of promoter: BRCA1’s promoter, Gene: GFP, Terminator: SV40

With a high enough level of ERβ, the CD47 promoter is activated the BAX protein will be expressed, which will start the pathway that will induce apoptosis in the cell. However, with a high enough level of ERα, the BRCA1 promoter is activated and the BCL2 protein will be expressed, which will bind to BAX and inhibit apoptosis in the cell.

Methods


The design of our plasmid dictated the methods used in the project. Below are descriptions of the methods employed and their purposes.

Experimental Design


To get an overview of the different experiments we have performed within the timeframe of the project, and what experiments we would have liked to have performed if we had more time, try exploring our experiment tree! To know more about the different methods, click on each spot on the tree.

NOTE: The experiments which we did not perform in time, were Dead Cell Stain, Caspase 3/7 assay and Transfection with Treatment Plasmid on both 12Z and HESC cells.


Protocols


The following protocols are for the experiments preformed in the BSL-1 laboratory.

If the PDF does not display correctly or if you're on a mobile device, you can download the PDF here.



The following protocols are for the experiments preformed in the BSL-2 laboratory.

If the PDF does not display correctly or if you're on a mobile device, you can download the PDF here.

×